ShareHope (8403-TW), the only medical supporting and logistic company listed in Taiwan formally announced it took a 46% participation in Consusafe, hence grabbing a controlling stake in a major surgical-dressing supply channel nationwide. According to ShareHope, this investment will strengthen the company’s core business, diversify market channels, lower purchasing cost, and enhance its R&D capability. All these benefits add value to ShareHope’s branding image and created a new milestone for its health supply group purchasing channel integration.
Founded in 1980, Consusafe is GMP, CE, and FDA certified, and is Taiwan’s largest manufacturer of surgical dressing and health supplies. It is licensed to produce and sell over 600 items, including surgical dressing supplies, respiratory care supplies, and anesthesia tubing supplies. Consusafe also operates a biotechnology platform that conducts new product R&D.
According to Dr. Fred Yang, board chairman of ShareHope, the scope of ShareHope businesses includes medical device leasing, health checkup services, medical specialty services, healthcare management and consulting, and medication and health supply group purchasing which currently accounts for 80% of its revenues. The company is running an innovative business model, and is expanding its market from northern Taiwan to the rest of the country and mainland China. Its customers include hospitals, pharmacies, and clinics. ShareHope is also introducing several new products to Taiwan, establishing a testing platform, and promoting SmartCare technology.
ShareHope’s competitive advantage comes from its three departments: health logistics, health management (health checkups), and medical specialty. The health logistics services provide customers with an efficient, tailor made, low-cost, and simplified group purchasing process. The health management department will benefit from the opportunity presented by the influx of more tourists from China. The medical specialty department hopes to provide medical device leasing and specialty services to 378 mid to small size hospitals it currently targets.